Quidel ROE 2006-2018 | QDEL

Current and historical return on equity (ROE) values for Quidel (QDEL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Quidel ROE for the three months ending December 31, 2018 was 31.73%.
Quidel ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.07B $0.43B 19.55%
2018-09-30 $0.04B $0.39B 11.25%
2018-06-30 $0.02B $0.37B 6.98%
2018-03-31 $0.01B $0.33B 4.44%
2017-12-31 $-0.01B $0.23B -4.10%
2017-09-30 $-0.01B $0.22B -2.81%
2017-06-30 $-0.00B $0.21B -0.48%
2017-03-31 $0.00B $0.22B 1.48%
2016-12-31 $-0.01B $0.20B -7.10%
2016-09-30 $-0.01B $0.20B -5.95%
2016-06-30 $-0.01B $0.19B -5.79%
2016-03-31 $-0.01B $0.20B -6.00%
2015-12-31 $-0.01B $0.22B -2.61%
2015-09-30 $0.00B $0.22B 0.42%
2015-06-30 $-0.00B $0.23B -1.70%
2015-03-31 $-0.00B $0.25B -0.86%
2014-12-31 $-0.01B $0.25B -3.53%
2014-09-30 $-0.01B $0.22B -6.32%
2014-06-30 $-0.01B $0.22B -5.41%
2014-03-31 $-0.01B $0.23B -3.16%
2013-12-31 $0.01B $0.22B 3.19%
2013-09-30 $0.02B $0.22B 7.02%
2013-06-30 $0.02B $0.22B 8.74%
2013-03-31 $0.02B $0.22B 8.62%
2012-12-31 $0.01B $0.20B 2.65%
2012-09-30 $-0.00B $0.19B -1.62%
2012-06-30 $-0.00B $0.18B -1.63%
2012-03-31 $-0.00B $0.19B -2.18%
2011-12-31 $0.01B $0.19B 3.83%
2011-09-30 $0.01B $0.18B 3.64%
2011-06-30 $0.00B $0.18B 0.68%
2011-03-31 $0.00B $0.18B 2.29%
2010-12-31 $-0.01B $0.11B -9.54%
2010-09-30 $0.01B $0.11B 7.59%
2010-06-30 $0.03B $0.12B 24.95%
2010-03-31 $0.03B $0.12B 28.39%
2009-12-31 $0.03B $0.13B 29.27%
2009-09-30 $0.02B $0.12B 17.12%
2009-06-30 $0.01B $0.10B 7.98%
2009-03-31 $0.01B $0.11B 6.05%
2008-12-31 $0.02B $0.12B 16.27%
2008-09-30 $0.02B $0.13B 18.42%
2008-06-30 $0.02B $0.11B 16.78%
2008-03-31 $0.02B $0.11B 16.59%
2007-12-31 $0.01B $0.11B 13.13%
2007-09-30 $0.02B $0.10B 23.53%
2007-06-30 $0.02B $0.09B 24.40%
2007-03-31 $0.02B $0.10B 22.64%
2006-12-31 $0.02B $0.10B 22.83%
2006-09-30 $0.01B $0.08B 14.77%
2006-06-30 $0.01B $0.09B 13.95%
2006-03-31 $0.01B $0.09B 16.97%
2005-12-31 $-0.01B $0.09B -11.65%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.365B $0.522B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
Canopy Growth (CGC) Canada $14.912B 0.00
ResMed (RMD) United States $14.218B 26.96
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Insulet (PODD) United States $4.900B 1642.60
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
Neogen (NEOG) United States $2.958B 48.10
NuVasive (NUVA) United States $2.784B 24.18
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
Cardiovascular Systems (CSII) United States $1.190B 854.00
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.88
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71